Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Share-based Compensation (2024 - 2025)

Historic Share-based Compensation for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q3 2025 value amounting to $7.0 million.

  • Indivior Pharmaceuticals' Share-based Compensation rose 1666.67% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.0 million, marking a year-over-year change of. This contributed to the annual value of $24.0 million for FY2024, which is 1428.57% up from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Share-based Compensation of $7.0 million as of Q3 2025, which was up 1666.67% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, Indivior Pharmaceuticals' Share-based Compensation registered a high of $8.0 million during Q2 2025, and its lowest value of $6.0 million during Q1 2024.